SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-14-002800
Filing Date
2014-03-21
Accepted
2014-03-21 17:23:05
Documents
16
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2218887z10-k.htm 10-K 1513154
2 EX-10.13 a2218887zex-10_13.htm EX-10.13 52055
3 EX-21.1 a2218887zex-21_1.htm EX-21.1 2800
4 EX-31.1 a2218887zex-31_1.htm EX-31.1 7508
5 EX-31.2 a2218887zex-31_2.htm EX-31.2 7499
6 EX-32.1 a2218887zex-32_1.htm EX-32.1 4975
13 G711212.JPG g711212.jpg GRAPHIC 73822
14 G103044.JPG g103044.jpg GRAPHIC 110028
15 G146011.JPG g146011.jpg GRAPHIC 100910
16 G13617.JPG g13617.jpg GRAPHIC 37763
  Complete submission text file 0001047469-14-002800.txt   8192474

Data Files

Seq Description Document Type Size
7 EX-101.INS kpti-20131231.xml EX-101.INS 909552
8 EX-101.SCH kpti-20131231.xsd EX-101.SCH 49672
9 EX-101.CAL kpti-20131231_cal.xml EX-101.CAL 76112
10 EX-101.DEF kpti-20131231_def.xml EX-101.DEF 274499
11 EX-101.LAB kpti-20131231_lab.xml EX-101.LAB 892751
12 EX-101.PRE kpti-20131231_pre.xml EX-101.PRE 447163
Mailing Address 2 MERCER ROAD NATICK MA 01760
Business Address 2 MERCER ROAD NATICK MA 01760 508-975-4820
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36167 | Film No.: 14711217
SIC: 2834 Pharmaceutical Preparations